BusinessNovan Announces First Patient Dosed in Phase 2 Molluscum Contagiosum Trial with SB206By Nasdaq OMXJan 25, 2018, 2:01 PM UTC
BusinessCidara Therapeutics to Report Third Quarter 2017 Financial Results and Provide Corporate UpdateBy Nasdaq OMXNov 1, 2017, 8:05 PM UTC
BusinessAssembly Biosciences Announces 2017 AASLD PresentationsBy Nasdaq OMXOct 2, 2017, 11:00 AM UTC
BusinessAssembly Biosciences Selects Next-Generation CpAM Candidate for Advancement into Clinical DevelopmentBy Nasdaq OMXSep 25, 2017, 11:00 AM UTC
BusinessAssembly Biosciences Announces Successful Completion of ABI-H0731 Phase 1a Trial and Upcoming Conference PresentationsBy Nasdaq OMXFeb 16, 2017, 12:05 PM UTC
BusinessAssembly Biosciences to Present Data on ABI-H0731 at AASLD 2016 Liver MeetingBy Nasdaq OMXNov 11, 2016, 1:00 PM UTC
